News

The Biden administration released a list of the first 10 prescription drugs Medicare will now be able to negotiate prices on, which could lead to a savings of some $100 billion over the next decade. The price negotiation was established as part of 2022’s Inflation Reduction Act and is a massive blow for Big Pharma, which has been fighting the plan in courts in at least eight lawsuits. The drugs are used to treat diabetes, cancer and heart disease, among other conditions. The White House said senior citizens paid $3.4 billion in out-of-pocket costs for the 10 medications in the past year. This is President Biden.

Articles You May Like

Day Trade vs Swing Trade vs Long Term Investing in Penny Stocks
3 High-Growth Finance Stocks to Buy as the Fed Cuts Rates Again
Best Time to Get Into a SPX 0-DTE Iron Condor
Trading Iron Condors for Earnings Releases & a Volatility Crush
Will There Be a Recession in 2026?